Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00781599 · ClinicalTrials.gov registry record · NA
Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers
A NA study of Smokers, sponsored by Nikki Nollen, PhD, MA.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT00781599 is a NA study of Smokers that has completed, run by Nikki Nollen, PhD, MA. The registered enrollment target is 72 participants, above the 41-participant average among 3 other Smokers trials with a reported enrollment target (76% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00781599, a NA study of Smokers, has completed, sponsored by Nikki Nollen, PhD, MA.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
Little is known about the support needed to improve compliance with Chantix for smoking cessation. This is a two arm pilot study of African American smokers to provide varying levels of side effect management and compliance support during a 12 week treatment period. The primary aim of the study is to estimate the effect of induction support compared to standard care in increasing compliance with Chantix at month 3
Conditions Studied
Interventions
- BEHAVIORAL Adherence Counseling
- DRUG Chantix
- BEHAVIORAL Standard Counseling
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00781599
The ClinicalTrials.gov registry entry for NCT00781599 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 41-participant average among 3 other Smokers trials with a reported enrollment target (76% higher). The listed sponsor is Nikki Nollen, PhD, MA, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smokers appearing as the primary indexed condition, and to 3 interventions - of which Adherence Counseling is the first listed.
NCT00781599 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT00781599 about?
NCT00781599 is a clinical study titled "Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers". Little is known about the support needed to improve compliance with Chantix for smoking cessation. This is a two arm pilot study of African American smokers to provide varying levels of side effect management and compliance support during a 12 week treatment period. The primary aim of the study is t...
What is the current status of trial NCT00781599?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2008-10. Estimated completion is 2010-03.
What conditions does trial NCT00781599 study?
This clinical trial studies the following conditions: Smokers.
What interventions are being tested in trial NCT00781599?
The interventions under investigation include: Adherence Counseling (BEHAVIORAL), Chantix (DRUG), Standard Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00781599?
This trial is sponsored by Nikki Nollen, PhD, MA, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00781599 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smokers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.